Ketoprofene Sale Di Lisina Zentiva Italia

Ketoprofen lysine, the active ingredient in Ketoprofene Sale Di Lisina Zentiva Italia, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is used to relieve pain and inflammation associated with musculoskeletal conditions in adults.

GNH USA supplies Ketoprofene Sale Di Lisina Zentiva Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Ketoprofen lysine is an NSAID that reduces inflammation and pain in several musculoskeletal and acute pain conditions.

- Rheumatoid arthritis: alleviates joint pain, swelling and stiffness. - Osteoarthritis: improves mobility by decreasing joint inflammation. - Acute musculoskeletal pain: provides rapid relief after injury or strain. - Dental pain: reduces postoperative discomfort following dental procedures.

Ketoprofen lysine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated liver enzymes.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Severe renal impairment or acute kidney injury. - Cardiovascular events such as myocardial infarction or stroke. - Anaphylactic reactions including bronchospasm. - Hepatotoxicity with jaundice.

When prescribing or dispensing ketoprofen lysine, consider the following safety measures.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding before use. - Monitor renal function: adjust or avoid in patients with existing kidney disease. - Evaluate cardiovascular status: use cautiously in those with heart disease. - Check for hypersensitivity: discontinue if rash, angioedema, or bronchospasm occurs. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ketoprofen lysine can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: potential rise in lithium serum concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible decline in renal function. - Diuretics: heightened risk of renal impairment and electrolyte imbalance. - Methotrexate: reduced clearance leading to toxicity.